2183 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Linical Co., Ltd. engages in pharmaceutical contract research projects providing consulting, monitoring, and quality control services to pharmaceutical companies. It operates through the Contract Research Organization (CRO) and Pharmaceutical business segments. The CRO business segment provides outsourced pharmaceutical development services. The Pharmaceutical business segment handles marketing support on products of the pharmaceutical companies. The company was founded by Kazuhiro Hatano on June 7, 2005 and is headquartered in Osaka, Japan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
2183 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company